gtag('event', 'click', { 'event_category': 'PDF Download' });
was successfully added to your cart.

Basket

Health Professionals BlogLiver Transplantation

Prevalence and associated factors of vertebral fractures in children with chronic liver disease with and without liver transplantation

Title: Prevalence and associated factors of vertebral fractures in children with chronic liver disease with and without liver transplantation

Source: Pediatric Gastroenterology, Hepatology and Nutrition 2024, 27 (3), 158-167  

Follow this link

Date of publication: May 2024

Publication type: Cross-sectional study

Abstract: Purpose: To evaluate the prevalence of vertebral fracture (VF) in children with chronic liver disease (CLD) with and without liver transplantation (LT) and to determine the associated factors.

Methods: A cross-sectional study was conducted. Patients aged 3-21 years with CLD both before and after LT were enrolled in the study. Lateral thoracolumbar spine radiographs were obtained and assessed for VF using Mäkitie’s method. Clinical and biochemical data were collected.

Results: We enrolled 147 patients (80 females; median age 8.8 years [interquartile range 6.0-11.8]; 110 [74.8%] in the LT group and 37 [25.2%] in the non-LT group). VF was identified in 21 patients (14.3%): 17/110 (15.5%) in the LT group and 4/37 (10.8%) in the non-LT group (p=0.54). Back pain was noted in only three patients with VF. In the univariate analysis, a height z-score below -2.0 (p=0.010), pre-LT hepatopulmonary syndrome (p=0.014), elevated serum direct and total bilirubin levels (p=0.037 and p=0.049, respectively), and vitamin D deficiency at 1-year post-LT (p=0.048) were associated with VF in the LT group. In multivariate analysis, height z-score below -2.0 was the only significant associated factor (odds ratio, 5.94; 95% confidence interval, 1.49-23.76; p=0.012) for VF. All VFs in the non-LT group were reported in males.

Conclusion: In children with CLD, VF is common before and after LT. Most patients with VF are asymptomatic. Screening for VF should be considered in patients with a height z-score below -2.0 after LT.

Leave a Reply

© 2019 Children's Liver Disease Foundation. All Rights Reserved.